Macquarie Group’s Avita Medical RCEL Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $138K | Buy |
+26,126
| New | +$138K | ﹤0.01% | 1561 |
|
2025
Q1 | – | Sell |
-623
| Closed | -$8 | – | 1781 |
|
2024
Q4 | $8 | Sell |
623
-241
| -28% | -$3 | ﹤0.01% | 1659 |
|
2024
Q3 | $9.26K | Sell |
864
-3,437
| -80% | -$36.8K | ﹤0.01% | 1630 |
|
2024
Q2 | $34.1K | Buy |
4,301
+3,318
| +338% | +$26.3K | ﹤0.01% | 1618 |
|
2024
Q1 | $16 | Buy |
983
+52
| +6% | +$1 | ﹤0.01% | 1704 |
|
2023
Q4 | $12.8K | Sell |
931
-910
| -49% | -$12.5K | ﹤0.01% | 1610 |
|
2023
Q3 | $26 | Sell |
1,841
-1,595
| -46% | -$23 | ﹤0.01% | 1637 |
|
2023
Q2 | $58.4K | Sell |
3,436
-892
| -21% | -$15.2K | ﹤0.01% | 1603 |
|
2023
Q1 | $60.5K | Buy |
+4,328
| New | +$60.5K | ﹤0.01% | 1622 |
|
2022
Q1 | – | Sell |
-26,176
| Closed | -$314K | – | 2632 |
|
2021
Q4 | $314K | Sell |
26,176
-5,700
| -18% | -$68.4K | ﹤0.01% | 1694 |
|
2021
Q3 | $565K | Buy |
31,876
+22,852
| +253% | +$405K | ﹤0.01% | 1667 |
|
2021
Q2 | $185K | Buy |
9,024
+8,448
| +1,467% | +$173K | ﹤0.01% | 1820 |
|
2021
Q1 | $11K | Sell |
576
-8,305
| -94% | -$159K | ﹤0.01% | 2382 |
|
2020
Q4 | $165K | Sell |
8,881
-3,406
| -28% | -$63.3K | ﹤0.01% | 1728 |
|
2020
Q3 | $375K | Buy |
+12,287
| New | +$375K | ﹤0.01% | 1473 |
|